Stratrix
Company data sheet · Boston Scientific

Boston Scientific: from profit to three straight losses.

Industry
Surgical & Medical Instruments & Apparatus
Headquarters
United States
Ticker
BSX (NYSE)
Sources
SEC filings (1995–2026), Stratrix's verified Decision Cases, market data and official economic statistics for the United States
Data as of
October 18, 2026
  1. From profit to three straight losses. Boston Scientific lost money every year from 2013 to 2015: $0.5 billion in all. 2016 was its first profit in four years: $0.3 billion.
  2. Leaders came and went. Boston Scientific filed 39 leadership changes since 2016, more than 91% of large manufacturers (the median is 20). The day after each, its shares fell a median 0.5 points against its sector.

Financial results

Fiscal yearRevenueNet income
2016$9.1 billion$0.3 billion
2017$9 billion$0.1 billion
2018$9.8 billion$1.7 billion
2019$10.7 billion$4.7 billion
2020$9.9 billion−$0.1 billion
2021$11.9 billion$1 billion
2022$12.7 billion$0.7 billion
2023$14.2 billion$1.6 billion
2024$16.7 billion$1.8 billion
2025$20.1 billion$2.9 billion

As reported in its annual filings. Losses in red.

The full data sheet · Data Plan

Everything behind these findings, ready for your board deck.

  • Market reaction to disclosed decisions: 69 decision filings since 2016, each linked to the SEC, with the share return against its sector and the S&P 500 the next day and the next year (44 with market data).
  • Economic context: 7 measures for the United States, every year since 2016, from the official sources.
  • Peer comparison: against 264 companies of its size in its sector.
  • Financial results: ten years of revenue, operating and net income, and every annual report, linked.
  • Methods and sources, so each number can be checked and cited.
Download the PDFDownload the ExcelSee the Data Plan

The full data sheet downloads with the Data Plan. To see exactly what you get first, open the Boeing sample PDF or Excel.